Form 8-K - Current report:
SEC Accession No. 0001628280-24-025800
Filing Date
2024-05-30
Accepted
2024-05-30 16:14:21
Documents
22
Period of Report
2024-05-28
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrk-20240528.htm   iXBRL 8-K 82403
2 EX-4.1 exhibit41-8xk.htm EX-4.1 545627
3 EX-4.2 exhibit42-8xk.htm EX-4.2 139090
4 EX-4.3 exhibit43-8xk.htm EX-4.3 134475
5 EX-4.4 exhibit44-8xk.htm EX-4.4 131468
6 EX-4.5 exhibit45-8xk.htm EX-4.5 137414
7 EX-5.1 exhibit51-8xk.htm EX-5.1 14705
8 EX-5.2 exhibit52-8xk.htm EX-5.2 65583
13 lllogo.jpg GRAPHIC 260497
  Complete submission text file 0001628280-24-025800.txt   1998636

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrk-20240528.xsd EX-101.SCH 3322
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrk-20240528_def.xml EX-101.DEF 17185
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrk-20240528_lab.xml EX-101.LAB 30664
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrk-20240528_pre.xml EX-101.PRE 18043
25 EXTRACTED XBRL INSTANCE DOCUMENT mrk-20240528_htm.xml XML 6179
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 241005555
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)